Made
20 July 2009
Laid before the National Assembly for Wales
21 July 2009
Coming into force
21 July 2009
The Welsh Ministers, in exercise of the powers conferred by sections 46, 203(9) and (10) of the National Health Service (Wales) Act 2006(1), make the following Regulations:
1.–(1) The title of these Regulations is the National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) (Amendment) (No.2) Regulations 2009 and they come into force on 21 July 2009.
(2) These Regulations apply in relation to Wales.
2.–(1) The National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) Regulations 2004(2) are amended as follows.
(2) In Schedule 2 (drugs or medicines to be ordered only in certain circumstances), in the entry for the drug Zanamivir (Relenza)–
(a) number the current paragraph for the entry in column 2 as "(1)"; and
(b) insert in columns 2 and 3 respectively–
"(2) Adult and child patients where–
|
Treatment and prophylaxis of influenza". |
Edwina Hart
Minister for Health and Social Services, one of the Welsh Ministers
21 July 2009
(This note is not part of the Regulations)
These Regulations amend the National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) Regulations 2004 ("the principal Regulations") which make provision as to the drugs, medicines or other substances that may be ordered for patients in the provision of medical services under a general medical services contract within the meaning of section 42 of the National Health Service (Wales) Act 2006.
Regulation 2 amends Schedule 2 to the principal Regulations (drugs or medicines to be ordered only in certain circumstances) to add further circumstances in which the drug Zanamivir (Relenza) may be ordered under such a contract to include pandemic disease (such as pandemic influenza) which poses a serious risk, or potentially a serious risk, to human health (or such a disease is anticipated imminently) and the supply of the drugs is in accordance with a protocol relating to that disease as provided for in article 12F of the Prescription Only Medicines (Human Use) Order 1997 or article 8 of the Medicines (Pharmacy and General Sale-Exemption) Order 1980.